Potential of afatinib in the treatment of patients with HER2-positive breast cancer

Elena Geuna,1 Filippo Montemurro,2–4 Massimo Aglietta,1–3,5 Giorgio Valabrega1–3,51Division of Medical Oncology, Institute for Cancer Research and Treatment, Candiolo, Turin, 2Institute for Cancer Research, Candiolo, Turin, 3Foundation of Piedmont Oncology,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Geuna E, Montemurro F, Aglietta M, Valabrega G
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2012
Materias:
Acceso en línea:https://doaj.org/article/5195c2dbcebd4e67a5602716f5648cfa
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!